Search - tctmd.com

Displaying 501 - 520 of 701

Sort: Relevancy | Date

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Yael L. Maxwell

July 10, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

June 18, 2015

News Daily News

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

June 18, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Daily News

Advantage of Radial PCI Most Apparent at Extremes of BMI

Caitlin E. Cox

June 05, 2015

News Daily News

La Ventaja de la PCI Radial es Más Evidente en Ambos Extremos del IMC

Caitlin E. Cox

June 05, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

June 04, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

News Daily News

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Todd Neale

May 11, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

L.A. McKeown

May 06, 2015

Advertisement

Symic Biomedical Selects Vascular Clinical Candidate

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Advantage of Radial PCI Most Apparent at Extremes of BMI

La Ventaja de la PCI Radial es Más Evidente en Ambos Extremos del IMC

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content